To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at sales@atcc.org. For Technical questions please contact tech@atcc.org. Thank you.

X

Skip to Content

Search

Login
|
Create a Profile
|
Quick Order
|
(0 items)
|
USA

Select another country:

|
1.800.638.6597

Acinetobacter baumannii Bouvet and Grimont (ATCC^® BAA-2884^™)

Click here to learn about our Enhanced Authentication Initiative

Strain Designations: 1147796 / Type Strain: no / Biosafety Level: 2

Acinetobacter baumannii Bouvet and Grimont ATCC^® BAA-2884^™

frozen

For-Profit: $650.00 Non-Profit: $650.00

Qty:

Permits and Restrictions	View Permits View Restrictions
Reports	Upon your purchase of this product, you will receive a report containing MIC values, a susceptibility profile, and the DNA sequence information for predicted annotated antibiotic resistance genes and 16S rRNA genes. This report will be provided in multiple formats (.pdf, .txt, .xls, .zip).
Deposited As	Acinetobacter baumannii
Verified By	Whole-genome Sequencing
Strain Designations	1147796
Application	Drug discovery and development Development of molecular-based detection assays Development of updated sterility protocols
Isolation	Blood
Isolation Date	2014
Geographic Source	United States
Biosafety Level	2 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format	frozen
Storage Conditions	-80°C or colder

Preceptrol®	no
Annotated Genes	abeM abeS ADC adeA adeB adeC adeF adeG adeH adeI adeJ adeK adeL adeS ANT2-Ia ANT(3'')-Ia ANT(3'')-II APH3-VI baeR baeS cat catB emrB macA macB msbA OXA-23 OXA-82 rlmN soxR sul1 tolC
Type Strain	no
MIC Range	Resistant Amikacin: ≥64 µg/mL Cefepime: ≥32 µg/mL Ceftazidime: ≥32 µg/mL Ceftriaxone: ≥64 µg/mL Ciprofloxacin: ≥4 µg/mL Colistin: ≥4 µg/mL Doripenem: ≥8 µg/mL Imipenem: ≥8 µg/mL Levofloxacin: ≥8 µg/mL Meropenem: ≥8 µg/mL Piperacillin-tazobactam: ≥128/4 µg/mL Tetracycline: ≥16 µg/mL
Comments	This strain is part of the Global Priority Superbugs collection. It is an extensively characterized antimicrobial-resistant clinical isolate with validated genotypic and phenotypic activity against a variety of drug classes. This strain is provided with geographic source information; an NGS-assembled whole genome sequence, including annotated antibiotic resistance and rRNA genes; and an expanded level of susceptibility data with MIC test results. Minimum inhibitory concentration (MIC) ranges for resistant, intermediate, and susceptible are based on criteria within the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 28^th Edition. Predicted antimicrobial resistance gene sequence data are provided for informational purposes only and are based on open reading frames (ORFs) identified and annotated from contigs produced during next-generation sequencing (NGS). ATCC does not warrant that the entire predicted antimicrobial resistance gene is present within the sequence prepared for lot-specific reports. Likewise, the information provided merely indicates that some portion of the sequence (whole or in part) is present based on analytical base pair alignment with known gene sequences.

Medium	ATCC^® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions	Temperature: 37°C Atmosphere: Aerobic

Name of Depositor	International Health Management Associates (IHMA), Inc.
Special Collection	Global Priority Superbugs
Chain of Custody	ATCC <-- International Health Management Associates (IHMA), Inc.
Isolation	Blood
Isolation Date	2014
Geographic Source	United States
Patient Age	66
Patient Gender	Male
References	Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 28th Edition. Wayne, PA. M100, 2018.

Permits	These permits may be required for shipping this product: The Clinical Isolates Collection (CIC) products are distributed under the additional terms of the Addendum for CIC Materials. It is required that the Addendum be signed and returned to ATCC prior to shipment. Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation	Product Sheet Certificate of Analysis SDS
Restrictions
Restrictions	Products in the Global Priority Superbugs collection are distributed under the additional terms of the Addendum for Global Priority Superbugs Materials. It is required that the Addendum be signed and returned to ATCC prior to shipment.
FAQs	Accessing genome sequencing data Date Updated: 9/30/2019 Criteria for reference quality genomes Date Updated: 9/30/2019